Publications

  1. Kim H, Gano D, Ho ML, Guo XM, Unzueta A, Hess C, Ferriero DM, Xu D, Barkovich AJ. Hindbrain regional growth in preterm newborns and its impairment in relation to brain injury. Hum Brain Mapp. 2016 Feb; 37 (2):678-88 Epub 2015 Nov 21
    View PubMed
  2. Unzueta A, Valdez R, Chang YH, Desmarteau YM, Heilman RL, Scott RL, Douglas DD, Rakela J. Hepatitis E virus serum antibodies and RNA prevalence in patients evaluated for heart and kidney transplantation. Ann Hepatol. 2016 Jan-Feb; 15 (1):33-40
    View PubMed
  3. Unzueta A, Valdez R, Chang YH, Desmarteau YM, Heilman RL, Scott RL, Douglas DD, Rakela J. Hepatitis E virus serum antibodies and RNA prevalence in patients evaluated for heart and kidney transplantation. Ann Hepatol. 2016 Jan - Feb; 15 (1):33-40
    View PubMed
  4. Unzueta A, Rakela J. Hepatitis E infection in liver transplant recipients. Liver Transpl. 2014 Jan; 20(1):15-24.
    View PubMed
  5. Unzueta A, Vargas HE. Nonsteroidal anti-inflammatory drug-induced hepatoxicity. Clin Liver Dis. 2013 Nov; 17 (4):643-56, ix Epub 2013 Sept 04
    View PubMed
  6. Unzueta A, Gallegos-Orozco JF. Noninvasive diagnosis of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. OGH Reports. 2013; 2(2):8-16.
  7. Unzueta A, Yamamoto JK, Uscanga LF. Lack of response to infliximab as treatment for preventing colectomy in patients with severe ulcerative colitis. Am J Gastroenterol. 2002; 97:S165.
  8. Unzueta-Santos A, Yamamoto-Furusho JK, Uscanga-Dominguez LF. Infliximab experience in inflammatory bowel disease (in Spanish). Rev Gastroenterol Mex. 2002; 67:A215.